Bottom line
IDNA vs LOGSX: the short answer
IDNA (iShares Genomics Immunology and Healthcare ETF) and LOGSX (Live Oak Health Sciences Fund) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.
But IDNA is far broader, holding 61 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
IDNA is cheaper at 0.47% vs 1.04% — a difference of $57 a year per $10,000 invested.
Over five years, LOGSX returned +8.1% a year vs −4.8% for IDNA (reporting dates differ).
Updated Nov 19, 2026
IDNA vs LOGSX side by side
| IDNA | LOGSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | Oak Associates |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.47% | 1.04% |
| Annual cost per $10k | $47 | $104 |
| 10-yr cost on $10k (prospectus) | $591 | $1,271 |
| Max front load | None | — |
| 12b-1 fee | 0% | — |
| 1-yr return | −1.0% | +19.6% |
| 5-yr return (annualized) | −4.8% | +8.1% |
| 10-yr return (annualized) | — | +7.3% |
| Best quarter | +41.9% | +13.4% |
| Worst quarter | −21.5% | −13.1% |
| Net assets (fund) | $190.9M | $56.1M |
| Number of holdings | 61 | 28 |
| Portfolio turnover | 49% | 24% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IDNA | LOGSX | Difference |
|---|---|---|---|
| 2024 | −1.0% | +0.2% | −1.2% |
| 2023 | −7.8% | +1.2% | −9.0% |
| 2022 | −42.1% | +3.7% | −45.8% |
| 2021 | −4.0% | +17.5% | −21.5% |
| 2020 | +54.5% | +6.0% | +48.5% |
Source: Fund prospectus bar charts
Holdings overlap
5 of IDNA's top 25 holdings also appear in LOGSX's top 25.
| Holding | IDNA | LOGSX |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4.35% | 4.43% |
| Incyte Corporation | 4.23% | 3.30% |
| Merck & Co., Inc. | 3.91% | 3.16% |
| Vertex Pharmaceuticals Incorporated | 3.87% | 3.26% |
| Exelixis, Inc. | 3.65% | 4.95% |
Source: SEC Form N-PORT
IDNA top 10
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
- Bayer Aktiengesellschaft — 4.81%
- Twist Bioscience Corp — 4.79%
- Revolution Medicines, Inc. — 4.55%
- Regeneron Pharmaceuticals, Inc. — 4.35%
- Genmab A/s — 4.23%
- Incyte Corporation — 4.23%
- Moderna, Inc. — 4.19%
- Takeda Pharmaceutical Company Limited — 4.05%
- Merck & Co., Inc. — 3.91%
LOGSX top 10
- N/a — 6.91%
- Cardinal Health Inc — 5.86%
- Jazz Pharmaceuticals Plc — 5.77%
- United Therapeutics Corp — 5.11%
- Exelixis Inc — 4.95%
- Amgen Inc — 4.86%
- Lantheus Holdings Inc — 4.68%
- Novartis Ag — 4.67%
- Mckesson Corp — 4.53%
- Cencora Inc — 4.46%
FAQ
What is the difference between IDNA and LOGSX?
Which is cheaper, IDNA or LOGSX?
Should I own both IDNA and LOGSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.